ASQII logo

ASQII

Operating

Robotic and AI tools for oncology, including a robotic arm that prepares chemotherapy drugs in sterile conditions

Updated Source: SLA Startup IndexHow we verify →
Employees
2-10

About ASQII

ASQII is a Tunisian healthtech startup building technology for cancer treatment. Its main product is a robotic arm that prepares drugs in a sterile atmosphere, including chemotherapy and parenteral nutrition bags, working alongside healthcare professionals with computer-vision monitoring of each preparation. The company also develops AI-driven decision-support tools for oncologists aligned with global treatment guidelines, and runs a prototyping lab focused on improving the patient journey.

ASQII is based in Tunis, was founded in 2021 by Adel Hamdi, and employs between 2 and 10 people. It holds Tunisia's Startup Act label, granted in September 2021.

  • Bridges

    Cloud platform for managing health insurance portfolios for insurers, payers, employers and TPAs · Tunisia

  • MedQuick

    Online medical supplies marketplace in Tunisia selling equipment, consumables and instruments to professionals and individuals, by unit or in bulk. · Tunisia

  • Medikadvisor

    Medical tourism platform arranging treatment and surgery stays in Tunisian partner clinics, with free quotes and personal assistance. · Tunisia

  • Linkivia

    SaaS platform connecting medical analysis laboratories for subcontracted tests, sample transport and a marketplace for surplus consumables. · Tunisia

  • Doqtoor

    Telemedicine platform offering teleconsultation and remote medical advice to members of partner insurers · Tunisia

  • Bird Notes

    CRM for pharmaceutical companies to plan and track medical rep visits and manage their sales force in Tunisia and Africa. · Tunisia

All 17 HealthTech startups in Tunisia

Frequently asked about ASQII

Where is ASQII based and when was it founded?
ASQII is headquartered in Tunis, Tunisia and was founded in 2021.
What sector is ASQII in?
ASQII operates in HealthTech, Hardware and Artificial Intelligence.